70 likes | 160 Views
Featured Article :. Assessment of Patient-Led or Physician-Driven Continuous Glucose Monitoring in Patients With Poorly Controlled Type 1 Diabetes Using Basal-Bolus Insulin Regimens.
E N D
Featured Article: Assessment of Patient-Led or Physician-Driven Continuous Glucose Monitoring in Patients With Poorly Controlled Type 1 Diabetes Using Basal-Bolus Insulin Regimens Jean-Pierre Riveline, M.D., Pauline Schaepelynck, M.D., Lucy Chaillous, M.D., Ph.D., Eric Renard, M.D., Ph.D., Agnès Sola-Gazagnes, M.D., Alfred Penfornis, M.D., Ph.D., Nadia Tubiana-Rufi, M.D., VéroniqueSulmont, M.D., BogdanCatargi, M.D., Ph.D., Céline Lukas, M.D., Régis P. Radermecker, M.D., Charles Thivolet, M.D., Ph.D., François Moreau, M.D., Pierre-Yves Benhamou, M.D., Ph.D., Bruno Guerci, M.D., Ph.D., Anne-Marie Leguerrier, M.D., Luc Millot, M.D., Claude Sachon, M.D., Guillaume Charpentier, M.D., Hélène Hanaire, M.D., For The EVADIAC Sensor Study Goup Diabetes Care Volume 35: 965-971 May, 2012
Study Objectives • The benefits of real-time continuous glucose monitoring (CGM) have been demonstrated in patients with type 1 diabetes • Aim was to compare the effect of two modes of use of CGM, patient-led or physician-driven, in subjects with poorly controlled type 1 diabetes Riveline J et al. Diabetes Care 2012;35:965-971
Study Design • 197 patients with type 1 diabetes aged 8–60 years with HbA1c > 8% randomly assigned to: • Patient-led CGM • Physician-driven CGM • Conventional self-monitoring of blood glucose • Glucose control outcomes assessed at 1 year Riveline J et al. Diabetes Care 2012;35:965-971
Conclusions • Both patient-led and physician-driven CGM provide similar long-term improvement in glucose control in patients with poorly controlled type 1 diabetes • Physician-driven CGM mode used fewer sensors. Riveline J et al. Diabetes Care 2012;35:965-971